MedTrace Logo

Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.

NCT05863091 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 211

Last updated 2023-05-17

No results posted yet for this study

Summary

The purpose of this study is to analyze the accuracy of respiratory and breathing patterns generated through impedance changes generated by a patch-type electrocardiogram device (HiCardi+ wearable patch device, Mezoo Co., Ltd.), targeting patients undergoing pulmonary function testing and ventilator application.

Conditions

Interventions

DEVICE

HiCardi+

A patch-type electrocardiogram device is attached to a patient undergoing pulmonary function tests.

DEVICE

HiCardi+

A patch-type electrocardiogram device is attached to a patient on a ventilator in an intensive care unit.

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-09
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863091 on ClinicalTrials.gov